Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Shepelkova (Moscow, Russian Federation), A. Zaytseva (Moscow, Russian Federation), V. Evstifeev (Moscow, Russian Federation), I. Stepanyan (Moscow, Russian Federation), E. Shmelev (Moscow, Russian Federation), V. Yeremeev (Moscow, Russian Federation). Micro Array screening of microRNA markers of interstitial lung diseases for differential diagnostics.. 1358

Member's Comments

No comment yet.

Related content which might interest you: Gene expression profiles of idiopathic interstitial pneumonias: Identification of disease-specific diagnostic markers and molecular therapeutic targets Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012 Metabolomic profiling of clinical sputum samples reveals novel biomarkers for the early identification of lung cancer patients Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Validation of diagnostic molecular markers in bronchial fluid for lung cancer Source: Annual Congress 2011 - Progress in endoscopy for the diagnosis of lung cancer Year: 2011 Enabling an interstitial lung disease genomic classifier on an automated platform Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia Year: 2021 Biomarker discovery, development, and implementation in interstitial lung diseases Source: Virtual Congress 2021 – Interstitial lung diseases: from disease mechanisms to novel treatment options Year: 2021 Circulating biomarkers and tumour molecular profiling in patients with non-small cell lung cancer Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015 Gene expression profiling: can we identify the right target genes? Source: Eur Respir Rev 2008; 17: 163-167 Year: 2008 The utility of bronchoscopically acquired tissue for successful lung cancer molecular profiling (LC-MP) Source: Annual Congress 2013 –Comfort, safety and effectiveness of bronchoscopy Year: 2013 Diagnosis of interstitial lung diseases using eNose technology Source: Virtual Congress 2020 – Promising biomarkers for idiopathic interstitial pneumonia Year: 2020 A multicenter evaluation of a new periostin detection kit for idiopathic pulmonary fibrosis Source: International Congress 2015 – Connective tissue disorders Year: 2015 Immunophenotyping and genic re-arrangement analysis in lymphocytic/lymphoproliferative disorders of the lungs Source: Annual Congress 2007 - Role of genomics and biological tools in the work-up of interstitial lung disease Year: 2007 Gene expression profiling reveal novel biomarkers in non-small cell lung cancer Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases Year: 2010 Altered circulating exosomal RNA profiles detected by next-generation sequencing in patients with severe asthma Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease Year: 2016 Gene expression profiling of lung adenocarcinoma by microarray analysis Source: Eur Respir J 2005; 26: Suppl. 49, 93s Year: 2005 Lung cancer detection by computer assisted analysis of novel biomarkers in induced sputum samples Source: Annual Congress 2008 - Novel targets in the molecular pathology of lung cancer and COPD Year: 2008 MicroRNA profiling in bronchial biopsies identifies altered expression in asthma and high levels of allergen-modulated epithelial microRNAs Source: Virtual Congress 2021 – Early manifestations of chronic respiratory disease: zooming in at the epithelial barrier Year: 2021 Gene expression patterns in lung emphysema. A gene microarray analysis Source: Eur Respir J 2002; 20: Suppl. 38, 87s Year: 2002 Diagnostic markers of lung cancer in bronquial fluid: Development of inmunoassays and validation Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010 Gene expression and cellular profiling in a rat bleomycin model of drug-induced interstitial lung disease (DIILD) Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair Year: 2020